
USFDA APPLICATION NUMBER - 22113 / DOSAGE - TABLET;ORAL - 4MG;200MG;10MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| CHLORPHENIRAMINE MALEATE(UNII: V1Q0O9OJ9Z) (CHLORPHENIRAMINE - UNII:3U6IO1965U) | CHLORPHENIRAMINE MALEATE | 4mg | 4mg |
| IBUPROFEN(UNII: WK2XYI10QM) (IBUPROFEN - UNII:WK2XYI10QM) | IBUPROFEN | 200mg | 200mg |
| PHENYLEPHRINE HYDROCHLORIDE(UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) | PHENYLEPHRINE HYDROCHLORIDE | 10mg | 10mg |
Inactive Ingredients
| Ingredient Name | Haleon US Holdings LLC |
|---|---|
| ACESULFAME POTASSIUM(23OV73Q5G9) | |
| CARNAUBA WAX(R12CBM0EIZ) | |
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |
| EGG PHOSPHOLIPIDS(1Z74184RGV) | |
| FERRIC OXIDE RED(1K09F3G675) | |
| GLYCERIN(PDC6A3C0OX) | |
| GLYCERYL DIBEHENATE(R8WTH25YS2) | |
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |
| LACTIC ACID, UNSPECIFIED FORM(33X04XA5AT) | |
| LECITHIN, SOYBEAN(1DI56QDM62) | |
| MALTODEXTRIN(7CVR7L4A2D) | |
| MEDIUM-CHAIN TRIGLYCERIDES(C9H2L21V7U) | |
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
| POLYDEXTROSE(VH2XOU12IE) | |
| POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990) | |
| PROPYL GALLATE(8D4SNN7V92) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| STARCH, CORN(O8232NY3SJ) | |
| SUCRALOSE(96K6UQ3ZD4) | |
| TALC(7SEV7J4R1U) | |
| TITANIUM DIOXIDE(15FIX9V2JP) | |
| TRIACETIN(XHX3C3X673) | |
| XANTHAN GUM(TTV12P4NEE) |